References
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb;382(8):727–733.
- Notification of COVID-19 infection. National Health Commission of the People’s Republic of China. [cited 2020 Aug 28]. http://www.nhc.gov.cn/xcs/yqtb/202002/17a03704a99646ffad6807bc806f37a4.shtml (in Chinese).
- World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-146[EB/OL]. [cited 2020 Aug 28]. https://www.who.int/docs/default-source/coronaviruse/situationreports/20200321-sitrep-61-covid-19.pdf?sfvrsn=f201f85c_2
- World Health Organization. Director-general’s remarks at the media briefing on 2019-nCoV on 11 February 2020. [ cited 2020 Feb 12]. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
- Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003 May;348(20):1953–1966.
- Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012 Nov;367(19):1814–1820.
- https://www.biorxiv.org/content/10.1101/2020.02.07.937862v1 [ cited 2020 Feb 12].
- Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020 Mar;14(1):69–71.
- Tang Decai XJ. Science of Chinese materia medica. Shanghai: Shanghai University of Traditional Chinese Medicine; 2006.
- Pan MH, Chiou YS, Tsai ML, et al. Anti-inflammatory activity of traditional Chinese medicinal herbs. J Tradit Complement Med. 2011 Oct;1(1):8–24.
- Wang Q, Kuang H, Su Y, et al. Naturally derived anti-inflammatory compounds from Chinese medicinal plants. J Ethnopharmacol. 2013 Mar 7;146(1):9–39.
- Wang Z, Chen X, Lu Y, et al. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020 Mar;14(1):64–68.
- Diagnosis and treatment of pneumonia caused by 2019-nCoV (version 6). [cited 2020 Feb 5]. http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml (in Chinese)
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497–506.
- Perlman S. Another decade, another coronavirus. N Engl J Med. 2020 Feb;382(8):760–762.
- Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb;395(10223):514–523.
- Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020 Feb;395(10223):470–473.
- Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 Mar;382(10):929–936.
- Lim J, Jeon S, Shin HY, et al. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci. 2020 Feb;35(6):e79.
- Wang Y, Ding Y, Yang C, et al. Inhibition of the infectivity and inflammatory response of influenza virus by arbidol hydrochloride in vitro and in vivo (mice and ferret). Biomed Pharmacother. 2017 Jul;91:393–401.
- News. [cited 2020 Feb 5]. http://www.sd.chinanews.com/2/2020/0205/70145.html (in Chinese)
- Chinese clinical trial registry. [cited 2019 Feb 5] http://www.chictr.org.cn/showproj.aspx?proj =49065
- Tao Z, Yang Y, Shi W, et al. Complementary and alternative medicine is expected to make greater contribution in controlling the prevalence of influenza. Biosci Trends. 2013 Oct;7(5):253–256.
- Ainsworth DM, Reyner CL. Effects of in vitro exposure to autologous blood and serum on expression of interleukin-8, interleukin-1β, and chemokine (C-X-C motif) ligand 2 in equine primary bronchial epithelial cell cultures. Am J Vet Res. 2012 Feb;73(2):296–301.
- Silva MA, Bercik P. Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells. Lab Invest. 2012 Jun;92(6):937–948.
- Yuan Y, Liao Q, Xue M, et al. Shufeng jiedu capsules alleviate lipopolysaccharide- induced acute lung inflammatory injury via activation of GPR18 by verbenalin. Cell Physiol Biochem. 2018;50(2):629–639.